You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Vaccination against RhoC induces long-lasting immune responses in patients with prostate cancer: results from a phase I/II clinical trial

Article metrics

Article menu
XML
Clinical/translational cancer immunotherapy
Original research
Vaccination against RhoC induces long-lasting immune responses in patients with prostate cancer: results from a phase I/II clinical trial

 

Online download statistics by month:

Online download statistics by month: November 2020 to March 2024

AbstractFullPdf
Nov 2020888888197
Dec 202046846892
Jan 202119319156
Feb 202123123139
Mar 202112212237
Apr 202111911934
May 2021929235
Jun 2021848418
Jul 2021747424
Aug 2021757515
Sep 2021949452
Oct 202140140195
Nov 202116816775
Dec 202113713845
Jan 202210310928
Feb 2022677224
Mar 20229910027
Apr 202210711323
May 202218119752
Jun 2022838831
Jul 2022535824
Aug 2022536022
Sep 2022505463
Oct 2022576332
Nov 2022687029
Dec 2022394016
Jan 2023464816
Feb 202371718
Mar 2023535431
Apr 2023323545
May 2023363612
Jun 2023424319
Jul 2023232320
Aug 202323247
Sep 2023313414
Oct 2023282817
Nov 2023454516
Dec 2023434316
Jan 202446246421
Feb 2024909139
Mar 2024414160
Total517252481526